These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7615497)
1. Inhibitory effect on the lipolysis-stimulated receptor of the 39-kDa receptor-associated protein. Troussard AA; Khallou J; Mann CJ; André P; Strickland DK; Bihain BE; Yen FT J Biol Chem; 1995 Jul; 270(29):17068-71. PubMed ID: 7615497 [TBL] [Abstract][Full Text] [Related]
2. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Yen FT; Mann CJ; Guermani LM; Hannouche NF; Hubert N; Hornick CA; Bordeau VN; Agnani G; Bihain BE Biochemistry; 1994 Feb; 33(5):1172-80. PubMed ID: 7509190 [TBL] [Abstract][Full Text] [Related]
3. Blockade of the alpha 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein on rat liver parenchymal cells by the 39-kDa receptor-associated protein leaves the interaction of beta-migrating very-low-density lipoprotein with the lipoprotein remnant receptor unaffected. Ziere GJ; van der Kaaden ME; Vogelezang CJ; Boers W; Bihain BE; Kuiper J; Kruijt JK; van Berkel TJ Eur J Biochem; 1996 Dec; 242(3):703-11. PubMed ID: 9022700 [TBL] [Abstract][Full Text] [Related]
4. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. Medh JD; Fry GL; Bowen SL; Pladet MW; Strickland DK; Chappell DA J Biol Chem; 1995 Jan; 270(2):536-40. PubMed ID: 7822276 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor. Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464 [TBL] [Abstract][Full Text] [Related]
6. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. Battey FD; Gåfvels ME; FitzGerald DJ; Argraves WS; Chappell DA; Strauss JF; Strickland DK J Biol Chem; 1994 Sep; 269(37):23268-73. PubMed ID: 8083232 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor. Mann CJ; Khallou J; Chevreuil O; Troussard AA; Guermani LM; Launay K; Delplanque B; Yen FT; Bihain BE Biochemistry; 1995 Aug; 34(33):10421-31. PubMed ID: 7654696 [TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. Yen FT; Masson M; Clossais-Besnard N; André P; Grosset JM; Bougueleret L; Dumas JB; Guerassimenko O; Bihain BE J Biol Chem; 1999 May; 274(19):13390-8. PubMed ID: 10224102 [TBL] [Abstract][Full Text] [Related]
10. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia. Bihain BE; Yen FT Biochemistry; 1992 May; 31(19):4628-36. PubMed ID: 1581314 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding. Horn IR; van den Berg BM; van der Meijden PZ; Pannekoek H; van Zonneveld AJ J Biol Chem; 1997 May; 272(21):13608-13. PubMed ID: 9153209 [TBL] [Abstract][Full Text] [Related]
13. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice. Yen FT; Roitel O; Bonnard L; Notet V; Pratte D; Stenger C; Magueur E; Bihain BE J Biol Chem; 2008 Sep; 283(37):25650-25659. PubMed ID: 18644789 [TBL] [Abstract][Full Text] [Related]
14. Lactoferrin and its hydrolysate bind directly to the oleate-activated form of the lipolysis stimulated lipoprotein receptor. Ahmad N; Girardet JM; Akbar S; Lanhers MC; Paris C; Yen FT; Corbier C FEBS J; 2012 Dec; 279(23):4361-73. PubMed ID: 23050782 [TBL] [Abstract][Full Text] [Related]
15. High-affinity uptake and degradation of apolipoprotein E free high-density lipoprotein and low-density lipoprotein in cultured porcine hepatocytes. Bachorik PS; Franklin FA; Virgil DG; Kwiterovich PO Biochemistry; 1982 Oct; 21(22):5675-84. PubMed ID: 6293555 [TBL] [Abstract][Full Text] [Related]
16. Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. Ellsworth JL; Kraemer FB; Cooper AD J Biol Chem; 1987 Feb; 262(5):2316-25. PubMed ID: 3546288 [TBL] [Abstract][Full Text] [Related]
17. 39-kDa receptor-associated protein (RAP) facilitates secretion and ligand binding of extracellular region of very-low-density-lipoprotein receptor: implications for a distinct pathway from low-density-lipoprotein receptor. Sato A; Shimada Y; Herz J; Yamamoto T; Jingami H Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):377-83. PubMed ID: 10393096 [TBL] [Abstract][Full Text] [Related]
18. The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330. Kounnas MZ; Argraves WS; Strickland DK J Biol Chem; 1992 Oct; 267(29):21162-6. PubMed ID: 1400426 [TBL] [Abstract][Full Text] [Related]
19. The chicken oocyte receptor for yolk precursors as a model for studying the action of receptor-associated protein and lactoferrin. Hiesberger T; Hermann M; Jacobsen L; Novak S; Hodits RA; Bujo H; Meilinger M; Hüttinger M; Schneider WJ; Nimpf J J Biol Chem; 1995 Aug; 270(31):18219-26. PubMed ID: 7543099 [TBL] [Abstract][Full Text] [Related]
20. Pseudo type III dyslipoproteinemia is associated with normal fibroblast lipoprotein receptor activity. Giroux LM; Cohn JS; LaMarre J; Davignon J Atherosclerosis; 1997 Jul; 132(1):85-94. PubMed ID: 9247363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]